Market Research Report
LAMEA Ventricular Assist Devices Market Analysis (2017-2023)
|Published by||KBV Research||Product code||639330|
|Published||Content info||74 Pages
|LAMEA Ventricular Assist Devices Market Analysis (2017-2023)|
|Published: April 30, 2018||Content info: 74 Pages||
The LAMEA Ventricular Assist Devices Market would witness market growth of 13.4% CAGR during the forecast period (2017 - 2023).
Ventricular assist devices are implantable mechanical pumps used in controlling the blood flow from ventricles of heart to the rest of body. These devices replicate the functioning of ventricles and are implanted to the end of heart and to helps the flow of blood from ventricles to the body. These flow pumps could be either pulsatile or continuous, where the continuous flow pump circulates blood continuously, while the pulsatile pump mimics the natural heart pulse.
The major factors that drive the growth of the global ventricular assist devices market are growing patients' pool with heart failures and shortage of heart donors. Additionally, the technically advanced VAD (DuraHeart, HeartMate III) are devices that add to the market growth. Nevertheless, these devices are costly, and also have risks such as blood clots and bleeding, which would limit the market growth significantly.
Based on product, the market report segments the market into Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular Assist Devices (BIVADs). Based on Application, the Global Ventricular Assist Devices market segments the market into Bridge-to-transplant (BTT) Therapy, Destination Therapy, Bridge-to-recovery (BTR) Therapy, and Bridge-to-candidacy (BTC) Therapy. Based on Design, the market report segments the market into Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices. The report also cover country wise segmentation. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the LAMEA Ventricular Assist Devices Market. Key companies profiled in the report include Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation, and Abiomed..